Literature DB >> 28535617

Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota.

P Ungprasert1, C S Crowson, E L Matteson.   

Abstract

Information about the epidemiology, clinical manifestations and comorbidities of sarcoidosis among Caucasians is relatively scarce. This review focuses primarily on the data from a recently published Caucasianpredominant population-based cohort from Olmsted County, Minnesota. Overall, the incidence rate was 10.0 per 100,000 population, which suggested that sarcoidosis is less common in Caucasians than in Blacks, but is more common in Caucasians than in Asians. Intrathoracic involvement was seen in the vast majority of patients, but less than half have respiratory symptoms. The most common extra-thoracic manifestations were skin rash followed by arthralgia, ophthalmologic involvement, hepatic involvement, splenomegaly, renal involvement, neurological involvement, extra-thoracic lymphadenopathy, exocrine gland involvement, upper respiratory tract involvement and cardiac involvement. Compared to sex and age-matched subjects, patients with sarcoidosis suffer from increased rates of cardiovascular disease, venous thromboembolism and hospitalized infection.

Entities:  

Mesh:

Year:  2017        PMID: 28535617      PMCID: PMC5521258          DOI: 10.4081/reumatismo.2017.965

Source DB:  PubMed          Journal:  Reumatismo        ISSN: 0048-7449


  50 in total

1.  A case control etiologic study of sarcoidosis: environmental and occupational risk factors.

Authors:  Lee S Newman; Cecile S Rose; Eddy A Bresnitz; Milton D Rossman; Juliana Barnard; Margaret Frederick; Michael L Terrin; Steven E Weinberger; David R Moller; Geoffrey McLennan; Gary Hunninghake; Louis DePalo; Robert P Baughman; Michael C Iannuzzi; Marc A Judson; Genell L Knatterud; Bruce W Thompson; Alvin S Teirstein; Henry Yeager; Carol J Johns; David L Rabin; Benjamin A Rybicki; Reuben Cherniack
Journal:  Am J Respir Crit Care Med       Date:  2004-09-03       Impact factor: 21.405

Review 2.  Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.

Authors:  F Montecucco; F Mach
Journal:  Rheumatology (Oxford)       Date:  2008-10-16       Impact factor: 7.580

3.  Cigarette smoking and ulcerative colitis: a case-control study.

Authors:  M D Silverstein; B A Lashner; S B Hanauer
Journal:  Mayo Clin Proc       Date:  1994-05       Impact factor: 7.616

4.  Seasonal variation in incidence of sarcoidosis: a population-based study, 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eric L Matteson
Journal:  Thorax       Date:  2016-08-18       Impact factor: 9.139

5.  Sarcoidosis-related mortality in the United States from 1988 to 2007.

Authors:  Jeffrey J Swigris; Amy L Olson; Tristan J Huie; Evans R Fernandez-Perez; Joshua Solomon; David Sprunger; Kevin K Brown
Journal:  Am J Respir Crit Care Med       Date:  2011-02-17       Impact factor: 21.405

6.  Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK.

Authors:  J Gribbin; R B Hubbard; I Le Jeune; C J P Smith; J West; L J Tata
Journal:  Thorax       Date:  2006-07-14       Impact factor: 9.139

Review 7.  Inflammation, innate immunity and blood coagulation.

Authors:  J Xu; F Lupu; C T Esmon
Journal:  Hamostaseologie       Date:  2010-01       Impact factor: 1.778

8.  Epidemiology of sarcoidosis in Japan.

Authors:  T Morimoto; A Azuma; S Abe; J Usuki; S Kudoh; K Sugisaki; M Oritsu; T Nukiwa
Journal:  Eur Respir J       Date:  2007-10-24       Impact factor: 16.671

9.  Clinical Characteristics of Sarcoid Arthropathy: A Population-Based Study.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eric L Matteson
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-05       Impact factor: 4.794

10.  Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis.

Authors:  Y H Lee; S J Choi; J D Ji; G G Song
Journal:  Lupus       Date:  2016-01-24       Impact factor: 2.911

View more
  7 in total

1.  Symptomatic hypercalcemia and scarring alopecia as presenting features of sarcoidosis.

Authors:  Jillian Frieder; Dario Kivelevitch; Alan Menter
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-03-15

Review 2.  Distinguishing Blau Syndrome from Systemic Sarcoidosis.

Authors:  Katherine P Kaufman; Mara L Becker
Journal:  Curr Allergy Asthma Rep       Date:  2021-02-09       Impact factor: 4.806

3.  Primary isolated hepatosplenic sarcoidosis mimicking malignancy and causing symptomatic hypercalcaemia.

Authors:  Tarek Haykal; Saira Sundus; Ghassan Bachuwa; Rizwan Danish
Journal:  BMJ Case Rep       Date:  2019-01-22

4.  Sarcoidosis in Jordan: A Study of the Clinical Phenotype and Disease Outcome.

Authors:  Fatima Alnaimat; Khaled Al Oweidat; Anas Alrwashdeh; Ahmad Alnashrati; Saba Barham; Mohammad Hijaz; Dina Murad; Sameeha Alshelleh; Nathir Obeidat
Journal:  Arch Rheumatol       Date:  2020-02-07       Impact factor: 1.472

5.  Spinal cord sarcoidosis in Japan: utility of cerebrospinal fluid examination and nerve conduction study for diagnosis and prognosis prediction.

Authors:  Miwako Fujisawa; Michiaki Koga; Ryota Sato; Mariko Oishi; Yukio Takeshita; Takashi Kanda
Journal:  J Neurol       Date:  2022-04-17       Impact factor: 6.682

6.  Prevalence and characteristics of cutaneous sarcoidosis in Argentina.

Authors:  Marina Abed Dickson; Bárbara Agustina Hernández; Sebastian Marciano; Luis Daniel Mazzuoccolo
Journal:  Int J Womens Dermatol       Date:  2021-01-19

7.  Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts.

Authors:  Hok Sreng Te; David M Perlman; Chetan Shenoy; Daniel J Steinberger; Rebecca J Cogswell; Henri Roukoz; Erik J Peterson; Lin Zhang; Tadashi L Allen; Maneesh Bhargava
Journal:  BMC Pulm Med       Date:  2020-06-01       Impact factor: 3.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.